Ronald L. Magolda

8.9k citations

69 papers · 5.6k indexed · 1 hit paper · h-index 29

Co-authors: James M. Trzăskos Margaret Favata Robert A. Copeland Peggy Scherle William J. Pitts Elizabeth J. Manos Frank W. Hobbs Kurumi Y. Horiuchi
Topics: Inflammatory mediators and NSAID effects (11 papers)Chemical Synthesis and Analysis (8 papers)Cytokine Signaling Pathways and Interactions (8 papers)
Cited by: Immunology and Allergy Cancer Research Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Canada Germany

In The Last Decade

Ronald L. Magolda

69 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase

1998 2.8k citations Margaret Favata, Kurumi Y. Horiuchi et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Ronald L. Magolda

Since Specialization

Citations

This map shows the geographic impact of Ronald L. Magolda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald L. Magolda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald L. Magolda more than expected).

Fields of papers citing papers by Ronald L. Magolda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald L. Magolda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald L. Magolda. The network helps show where Ronald L. Magolda may publish in the future.

Co-authorship network of co-authors of Ronald L. Magolda

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald L. Magolda. A scholar is included among the top collaborators of Ronald L. Magolda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald L. Magolda. Ronald L. Magolda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyridinyl aminohydantoins as small molecule BACE1 inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Ping Zhou,Yanfang Li,Yi Fan,Zheng Wang,Rajiv Chopra,Andrea Olland,Yun Hu,Ronald L. Magolda,Menelas N. Pangalos,Peter H. Reinhart,(unknown),Jonathan Bard,Michael S. Malamas,Albert J. Robichaud	27
2	Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT_1Areceptor antagonist and potential novel antidepressant 2009 ·British Journal of Pharmacology ·(unknown),Qian Lin,Brian J. Platt,Jessica E. Malberg,Geoffrey Hornby,KM Sullivan,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ronald L. Magolda,(unknown),(unknown),Sharon Rosenzweig‐Lipson,(unknown)	8
3	Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: Part II 2009 ·Bioorganic & Medicinal Chemistry ·William Moore,Jeffrey C. Kern,Ramesh A. Bhat,Peter V.N. Bodine,(unknown),Girija Krishnamurthy,Ronald L. Magolda,Keith Pitts,(unknown),Eugene J. Trybulski	18
4	Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia 2009 ·Journal of Medicinal Chemistry ·Benjamin E. Blass,Andrew Fensome,Eugene J. Trybulski,Ronald L. Magolda,Stephen J. Gardell,Kun Liu,(unknown),Irene Feingold,Christine Huselton,C. M. Jackson,(unknown),Douglas M. Ho,James K. Hennan,John M. Janusz	16
5	Prodrugs of Perzinfotel with Improved Oral Bioavailability 2009 ·Journal of Medicinal Chemistry ·(unknown),John A. Butera,Magid Abou‐Gharbia,Hong Chen,Boyd L. Harrison,(unknown),Ronald L. Magolda,Jean Y. Sze,Michael R. Brandt,Terri Cummons,(unknown),Menelas N. Pangalos,Bojana Zupan,Matthew Hoffmann,Michael J. May,(unknown),Jeffrey D. Kennedy,Wayne E. Childers	27
6	Itk kinase inhibitors: Initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead 2008 ·Bioorganic & Medicinal Chemistry Letters ·K.J.M. Moriarty,Michael P. Winters,Lei Qiao,Declan Ryan,(unknown),(unknown),Brian N. Cook,Mohammed A. Kashem,Paul V. Kaplita,(unknown),(unknown),(unknown),(unknown),Steven S. Pullen,Gregory P. Roth,Ronald L. Magolda,Hidenori Takahashi	23
7	Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists 2007 ·Bioorganic & Medicinal Chemistry ·Hassan Elokdah,David Li,(unknown),Ronald C. Bernotas,Albert J. Robichaud,Ronald L. Magolda,(unknown),Deborah L. Smith,Lee E. Schechter	13
8	Rational design, synthesis and structure–Activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 1: lead identification 2003 ·Bioorganic & Medicinal Chemistry Letters ·Chu‐Biao Xue,(unknown),John Roderick,(unknown),James J.‐W. Duan,Rui‐Qin Liu,Maryanne Covington,Robert Newton,James M. Trzăskos,Ronald L. Magolda,Ruth R. Wexler,Carl P. Decicco	21
9	Rational design, synthesis and structure–activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 2: lead optimization 2003 ·Bioorganic & Medicinal Chemistry Letters ·Chu‐Biao Xue,(unknown),John Roderick,(unknown),James J.‐W. Duan,Rui‐Qin Liu,Maryanne Covington,Mingxin Qian,Maria Ribadeneira,Krishna Vaddi,David D. Christ,Robert Newton,James M. Trzăskos,Ronald L. Magolda,Ruth R. Wexler,Carl P. Decicco	26
10	Inhibition of MAP Kinase Kinase (MEK) Results in an Anti-inflammatory Response in Vivo 2000 ·Biochemical and Biophysical Research Communications ·Bruce Jaffee,Elizabeth J. Manos,Robert J. Collins,(unknown),Margaret Favata,Ronald L. Magolda,Peggy Scherle,James M. Trzăskos	47
11	Aggrecanase: A Target for the Design of Inhibitors of Cartilage Degradation 1999 ·Annals of the New York Academy of Sciences ·Elizabeth C. Arner,(unknown),Carl P. Decicco,Chu‐Biao Xue,Robert C. Newton,James M. Trzăskos,Ronald L. Magolda,(unknown)	47
12	Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the central ring and o-biphenyl analogs 1999 ·Bioorganic & Medicinal Chemistry Letters ·Donald Pinto,Douglas G. Batt,William J. Pitts,Joseph J. Petraitis,Michael J. Orwat,Shuaige Wang,James W. Jetter,(unknown),(unknown),Robert A. Copeland,Maryanne Covington,James M. Trzăskos,Ronald L. Magolda	17
13	Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinasebreakdown → 1998 ·Journal of Biological Chemistry ·Margaret Favata,Kurumi Y. Horiuchi,Elizabeth J. Manos,(unknown),(unknown),(unknown),Drew E. Van Dyk,William J. Pitts,Richard A. Earl,Frank W. Hobbs,Robert A. Copeland,Ronald L. Magolda,Peggy Scherle,James M. Trzăskos	2750
14	Inhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy 1998 ·The Journal of Immunology ·(unknown),Elizabeth A. Jones,Margaret Favata,Bruce Jaffee,Ronald L. Magolda,James M. Trzăskos,Peggy Scherle	275
15	Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent brequinar sodium 1998 ·Bioorganic & Medicinal Chemistry Letters ·William J. Pitts,James W. Jetter,Donald Pinto,Michael J. Orwat,Douglas G. Batt,(unknown),Joseph J. Petraitis,(unknown),Robert A. Copeland,Randine L. Dowling,Bruce Jaffee,(unknown),Elizabeth A. Jones,Ronald L. Magolda	15
16	2,5-Diarylisothiazolone: novel inhibitors of cytokine-induced cartilage destruction 1996 ·Bioorganic & Medicinal Chemistry ·Stephen W. Wright,Joseph J. Petraitis,Bruce Freimark,John Giannaras,Michael A. Pratta,(unknown),Jean Williams,Ronald L. Magolda,Elizabeth C. Arner	12
17	Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors 1989 ·Journal of Cellular Biochemistry ·Ronald L. Magolda,W Galbraith	15
18	Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. 1980 ·Proceedings of the National Academy of Sciences ·Allan M. Lefer,Edward F. Smith,H Araki,J. Bryan Smith,David Aharony,David A. Claremon,Ronald L. Magolda,K. C. Nicolaou	102
19	Prostaglandin I2 as a potentiator of acute inflammation in rats 1978 ·Prostaglandins ·Keiji Komoriya,Hitoshi Ohmori,(unknown),Seizi Kurozumi,Yoshiro HASHIMOTO,K. C. Nicolaou,W. E. Barnette,Ronald L. Magolda	46
20	Synthesis of prostaglandin (PGH2) and prospacyclin (PGI2) analogs: tetrathia-PGH2 and PGI2-ketal methyl ester 1978 ·Prostaglandins and Medicine ·K. C. Nicolaou,W. E. Barnette,Ronald L. Magolda	3

About Ronald L. Magolda

Ronald L. Magolda is a scholar working on Pharmaceutical Science, Biochemistry and Pharmacology, having authored 69 papers that have together received 5.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Chemical Synthesis and Analysis (8 papers) and Cytokine Signaling Pathways and Interactions (8 papers). The work is most often cited by research in Immunology and Allergy (319 citations), Cancer Research (675 citations) and Molecular Biology (3.0k citations). Ronald L. Magolda has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include James M. Trzăskos, Margaret Favata, Robert A. Copeland, Peggy Scherle, William J. Pitts, Elizabeth J. Manos, Frank W. Hobbs, Kurumi Y. Horiuchi, Drew E. Van Dyk and Richard A. Earl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact